Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Shares Outstanding (Weighted Average) (2021 - 2025)

Senti Biosciences has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $22.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 389.2% year-over-year to $22.5 million; the TTM value through Dec 2025 reached $22.5 million, up 389.2%, while the annual FY2025 figure was $22.5 million, 389.2% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $22.5 million at Senti Biosciences, up from $20.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $44.1 million in Q1 2023 and troughed at $2.9 million in Q3 2021.
  • A 5-year average of $11.6 million and a median of $4.6 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 1289.7% in 2023 and later crashed 89.63% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $2.9 million in 2021, then skyrocketed by 796.58% to $26.1 million in 2022, then crashed by 83.01% to $4.4 million in 2023, then increased by 3.58% to $4.6 million in 2024, then skyrocketed by 389.2% to $22.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SNTI at $22.5 million in Q4 2025, $20.8 million in Q3 2025, and $26.1 million in Q2 2025.